BALLOON POST-DILATION OUTCOMES FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT AT A SINGLE COMMUNITY CARDIOVASCULAR CENTER  by Miller, Mistyann-Blue et al.
TCT@ACC-i2: Interventional Cardiology
A1897
JACC March 17, 2015
Volume 65, Issue 10S
balloon post-dilation oUtComes FollowinG transCatheter aortiC valve 
replaCement at a sinGle CommUnity CardiovasCUlar Center
Poster Contributions
Poster Hall B1
Sunday, March 15, 2015, 3:45 p.m.-4:30 p.m.
Session Title: Pharmacotherapy and Complex Coronary Interventions
Abstract Category: 30. TCT@ACC-i2: Aortic Valve Disease
Presentation Number: 2103-315
Authors: Mistyann-Blue Miller, Saif Al Yaseen, Arvind Kapila, Marcos Nores, Lawrence Lovitz, University of Miami Miller School of Medicine 
Regional Campus, Atlantis, FL, USA, JFK Medical Center, Atlantis, FL, USA
background: Paravalvular leak is a significant clinical predictor of mortality after transcatheter aortic valve replacement (TAVR). Intra-
operative balloon post-dilation remains the most commonly used method to reduce paravalvular leak. However, no studies have compared 
outcomes of those patients who required post-dilation at a single community cardiovascular center.
methods: The charts of subjects who underwent successful TAVR at a single institute were retrospectively reviewed. Requirements for 
post-dilation included those who had more than mild paravalvular leak after initial bioprosthetic implantation, which was assessed by 
intraoperative transesophageal echocardiography (TEE). Clinical outcomes included thirty-day all-cause mortality, incidence of new post-
operative atrial fibrillation (AF) and new complete heart block (CHB). In addition, the correlation between balloon post-dilation, valve size, 
and basal ring area determined from cardiac computed tomography (CT) 3-dimensional (3D) reconstruction were also evaluated.
results: One hundred and seven consecutive patients underwent successful implantation of an Edwards Sapien aortic transcatheter valve. 
Of these, thirty-six percent (n=39) required post-dilation intraoperatively. There was no difference in the 30-day all-cause mortality between 
the two groups (p=0.6). In regards to new CHB, no significant difference was observed; however incidence of AF, although not statistically 
significant, was notably higher in the group that did not undergo post-dilation (p=0.06). The mean basal ring area (mm2) was significantly 
higher in the post-dilation group versus the no-post-dilation group (441 vs 386 mm2), which correlated with the need for the larger (26mm) 
heart valve (p=0.003, 95% CI, .58 to 0.67).
Conclusion:  Balloon post-dilation immediately following transcatheter aortic valve deployment remains one of the most widely used 
methods in reducing paravalvular leak. No difference in outcomes were observed between those who required intra-operative balloon post-
dilation versus subjects who did not. However, the need for post-dilation was associated with a larger basal ring area and valve size.
